$ADM

Trump and Xi Buy Time on Trade. Farm and Chip Stocks Are Watching Closely.

China's soybean commitments boosted Archer-Daniels-Midland's (ADM) EPS guidance to $5.15-$5.60. Deere (DE) expects 15-20% decline in large-ag equipment sales in 2026. Nvidia (NVDA) assumes no China Data Center revenue in Q2 guidance of $108B. U.S.-China trade truce extended by two months, focusing on farmers, not semiconductors. China is meeting soybean commitments but lags on other farm purchases.

Original reporting
Published Sep 25, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 3:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Trump and Xi Buy Time on Trade. Farm and Chip Stocks Are Watching Closely. — source image
Decision brief

The 30-second read

$ADMBullishMed
01

Why it matters

These disclosures provide new valuation inputs for the listed companies and signal sector‑specific risk/reward dynamics.

02

Market read

Guidance lifts and sales forecasts directly affect stock valuations and sector sentiment, especially in agriculture and AI hardware.

03

What to watch

Potential downstream effects on fertilizer demand and logistics could amplify ADM's upside beyond the guidance lift.

Relevance 6/10Novelty 6/10Timing: today

Background

The article reports fresh guidance updates for ADM and Deere, plus Nvidia's quarterly outlook, amid a U.S.–China trade truce extension.

Company-level read

Ticker impact

$ADMBullishHigh confidence
Context

ADM raised full-year adjusted EPS guidance to $5.15‑$5.60 after China met soybean commitments.

Expected impact

Potential upside of 3‑5% on earnings revision.

Evidence & confidence

Guidance lift is a fresh, material update directly affecting valuation.

$DEBearishHigh confidence
Context

Deere (DE) projects large‑ag equipment sales to fall 15‑20% in 2026, confirming a weak demand outlook.

Expected impact

Potential downside of 2‑4% as investors price in lower revenue.

Evidence & confidence

Explicit sales decline forecast is a new, material data point.

$NVDANeutralMedium confidence
Context

Nvidia (NVDA) guided $108 B for the next quarter assuming zero China data‑center revenue.

Expected impact

Likely limited immediate move; price may stay flat pending AI capex trends.

Evidence & confidence

Guidance is a fresh disclosure but the assumption of zero China revenue is already baked in.

Market effects

Agribusiness and equipment sectors face divergent outlooks; AI chip sector remains insulated from China policy.

U.S. agribusiness may benefit from China soybean commitments, while U.S. equipment faces headwinds.

China's trade truce extension influences commodity and AI supply chains worldwide.

Counterpoint

If AI capex accelerates faster than expected, Nvidia could outperform despite the zero‑China assumption.

Key entities

  • Archer‑Daniels‑Midland

    Agribusiness firm receiving updated EPS guidance.

  • Deere & Company

    Equipment maker forecasting a sales decline.

  • Nvidia

    Chipmaker projecting revenue without China data‑center sales.

Related articles

$BPMed

Wall Street analyst calls for the week of Sep 21–25, 2026

Wall Street analysts highlighted energy, AI infrastructure, and agriculture as key themes. BP (BP) and Chevron (CVX) were upgraded, while TotalEnergies (TTE) saw mixed views. Marathon Petroleum and Akamai (AKAM) were noted for AI infrastructure. Deere & Company (DE) rose on crop price expectations. Moderna (MRNA) faced polarizing views ahead of trial results.

$NVDAMed

Nvidia Stock Moves Lower as Einride Scales Physical AI

Nvidia (NVDA) shares fell to $224.80 Friday after partnering with Einride to supply AI tools for driverless trucks. Einride expects demand for 1,500-2,000 vehicles by 2028, but revenue impact for Nvidia is unclear. Nvidia's GF Score is 96/100, with profitability and growth strengths noted.

$ADMMed

ADM’s Infant Probiotic Trial: A New Data Catalyst In Consumer Health

Archer-Daniels-Midland (ADM) completed a clinical trial testing a probiotic for infant colic relief. The double-blinded, placebo-controlled study aims to support ADM's position in science-backed nutrition. Positive results could boost ADM's pediatric nutrition sales and stock sentiment. The trial was updated on September 22, 2026, with data analysis underway.

$NVDAMed

Goldman Sachs: AI Infrastructure Valuations Fall as Spending Climbs Toward $1.1 Trillion

Goldman Sachs reports AI infrastructure stocks' valuations have dropped to 22x earnings, down from 32x in April, amid spending estimates reaching $1.1T by 2027. Memory chip stocks trade at 4x earnings, while chip designers show more stable margins. Goldman maintains Buy ratings on Nvidia (NVDA) and Broadcom (AVGO), Neutral on Micron (MU). Cloud providers' spending may reach $800B in 2024, requiring $300B in annual AI revenue to break even by 2026-2027.

$NVDAMedAI 8/10

What Does NVIDIA Offer That Texas Instruments Does Not?

NVIDIA (NVDA) and Texas Instruments (TXN) both sell chips for data centers, but NVIDIA's revenue is more concentrated in this area. NVIDIA's Q2 2027 data center revenue was $89B, with Q3 guidance at $108B. TI's Q2 revenue was $5.5B, with Q3 guidance between $5.65B and $6.15B. NVIDIA faces supply constraints, while TI has spare capacity. NVIDIA's gross margin is expected to decline to 71-72% by Q4. NVIDIA leads in growth, profit margins, and debt metrics.

$NVDAMedAI 8/10

Nvidia Stock Rises as Elon Musk Reveals Huge New AI Chip Plans

Nvidia NVDA shares rose 1% after SpaceX announced plans to add 660,000 Nvidia GB300 processors to its Colossus 2 facility by year-end. SpaceX also has a deal with Anthropic for 325,000 Nvidia GPUs, with $1.25B monthly payments post-ramp. The expansion highlights AI computing infrastructure growth across Musk's businesses.